Week 9 & 10 Flashcards
1
Q
Substance Use Disorder DSM 5
A
- Substance specific (primary & contemporaneous substances)
- Patterns of symptoms resulting from use of substance
- Continue to take despite experiencing a problem as a result
2
Q
Substance Induced Disorder DSM-5
A
- Intoxication, withdrawal
- Reversible substance specific syndrome due to recent ingestion/exposure to substance
3
Q
Behavioral Addiction DSM 5
A
Addictive activity becomes problem when it affects daily activities, health, finances
4
Q
Concurrent Disorder
A
- Substance use disorder & co-occurring mental health disorder(s)
- Challenges with integration of treatment
- Mutually reinforcing
5
Q
Substance Use Continuum
A
- No use
- Beneficial use
- Non-problematic
- Problematic
- Potentially harmful
- Substance use disorder
6
Q
Substance Use Screening
A
- Identify patients who are likely to have
- Inquiring about substance use (determine need for comprehensive)
7
Q
Substance Use Comprehensive Assessment
A
- May use standardized assessment tools
- Substances, route, source
- Onset of use/change in pattern of use
- Quantity, frequency
- Triggers
- Prior treatment
- Goals
8
Q
Opioid Intoxication S/S
A
- Decrease RR & BP
- Drowsiness
- Impairment of attention, judgement, memory
9
Q
Opioid Overdose S/S
A
- Respiratory depression
- Coma
- Shock, convulsions
- Pinpoint pupils
- Unconscious
- Blue lips
10
Q
Opioid Withdrawal S/S
A
- N/V
- Muscle aches
- Sweating
- Diarrhea
- Insomnia
- Lacrimation
- Agitation
11
Q
Alcohol Intoxication S/S
A
- Impairment of inhibition & control
- Emotional lability
- Impaired motor & cognitive function
12
Q
Alcohol Overdose S/S
A
- Respiratory depression
- Coma
- Shock
- Convulsions
13
Q
Alcohol Withdrawal S/S
A
- N/V
- Tremor
- Auditory/tactile disturbances
- Agitation
- Autonomic increase BP/HR
- Seizures, delirium
14
Q
Alcohol Comorbidities
A
- Wernicke’s encephalopathy
- Korsakoff syndrome
- Esophagitis
- GI bleeding & ulcers
- Esophageal varices
- Hepatitis
- Liver cirrhosis
- Spider angioma
15
Q
Acute OD
A
- Medical emergency
- Goal stabilize & support physiological symptoms
- Pharm intervention - antidotes
16
Q
Antidotes
A
- Naloxone
- Acetaminophen
- Benzo - flumazenil
- Alcohol - activated charcoal/gastric lavage
17
Q
ABCDE
A
- Airway - choking, vomiting
- Breathing - RR, SpO2, oxygenation support
- Circulation - perfusion, body temp, fluid balance
- Disability - neurological, GCS, seizures
- Examination - injuries
18
Q
Acute Withdrawal
A
- Goal stabilize & support physiological symptoms
- Pharm intervention - symptom management meds
- Physiological - fever, nausea, pain, diarrhea, sweating
- Psychological - depression, anxiety, irritability
- Safety - agitation, aggression
19
Q
Withdrawal Timeline
A
- Start - last dose
- 72h - peak physical symptoms
- 1wk - physical symptoms lessen
- 2wk - psychological & emotional symptoms
- 1mth - cravings & depression
20
Q
Alcohol Withdrawal Pharm Interventions
A
- Thiamine
- Folic acid multivitamins
- Benzos
21
Q
Opioid Withdrawal Meds
A
- Methadone, buprenorphine, suboxone
- Clonidine
22
Q
Chronic Recovery Goal
A
- Treatment retention
- Reduction of severity/frequency
- Reduce harm
- Manage comorbid conditions
- Improve QOL
- Prevent relapse
23
Q
Methadone
A
- Synthetic opioid
- 1-20 years of treatment
- Risk of misuse
24
Q
Suboxone
A
- Partial opioid agonist
- Long acting opioid (buprenorphine) & naloxone combo
25
Road to Addiction Recovery
- 1 to 1 support
- Medication assisted treatment
- Triggers
- Treatment plan
- Ongoing support network
26
Addiction Cycle
- Emotional trigger
- Craving
- Ritual
- Using
- Guilt
27
Recovery & Relapse Nurse Role
- Compassionate care
- Moral distress
- Support for self
28
Primary Prevention - Substance Use
Healthy public policy
29
Secondary Prevention - Substance Use
- Harm reduction
- Relapse prevention
- Community support programs
30
Tertiary Prevention - Substance Use
Specialized residential treatment program
31
Neurodevelopment Disorder
Significant development delay/deficit in 1+ lines of development that impair functioning
32
Neurocognitive Disorder
Acquired condition due to underlying brain pathology resulting in decreased cognitive function
33
Neurobehavioral Disorder
- Interchangeable term for many conditions now classified as neurodevelopmental
- Used to define ADHD & OCD as neurobehavioral
34
Risk Factors - Neurodev
- Compromises ability to move through normal developmental phases
- SDoH
- Parents with depression
- Parents/adult role modelling coping strategies
- Witnessing violence
- Disrupted attachment
35
Protective Factors - Neurodev
- Supports ability to move through normal developmental phases
- Resiliency
- Normal attachment
- Environment
36
Autism Spectrum Disorder
- Impairments of development in social interaction
- Communication with restrictive repertoire of repetitive activity & interest
- Uneven pattern of intellectual strengths & weaknesses
37
ADHD
- Altered degree of inattention , impulsivity, hyperactivity
- Symptoms present in 2+ settings
- Symptoms present before age of 12
38
Inattention Definition
- Difficulty listening
- Easily distracted
- Forgetfulness
- Inattention to social cues
39
Hyperactivity Definition
- Excessive motor activity
- Movement & utterances when not appropriate/purposeless
40
Fetal Alcohol Spectrum Disorder (FSAD)
- Exposure to alcohol before birth
- Physical & cognition implications
- Unclear how much alcohol to impact development
41
Client Assessment - Neurodev
- Social functioning
- Maladaptive behaviors
- Academic functioning
- Physical/health co-morbidities
- Interventions
42
Family Assessment - Neurodev
- SDoH
- Family functioning
- Risk
- Family medical history
43
Non-Pharm Intervention - Neurodev
- Health teaching
- Family therapy
- Group therapy
44
Autism Meds
- Anti-psychotics (decrease irritability & liability)
- SSRI (decrease compulsive behavior)
- Beta Blockers (decrease aggression & severe anxiety)
45
ADHD Meds
- Psychostimulant
- Non-stimulant SNRI
46
Methylphenidate (concerta, ritalin)
- CNS stimulant
- Common for ADHD
- Short acting started at 1 dose/day
- Increase to 2-3 dose/day
- Long acting taken 1/day
47
Amphetamines (adderall, vyvanse)
- CNS stimulant
- Common for ADHD
- Short & long acting available
48
Psychostimulant Side Effects
- Decrease appetite
- Weight loss
- Insomnia
49
Animal Assisted Mindfulness Training
- Help develop effective emotional regulation skills
- Form deep connections with animals
- Impact on overall mental well-being
50
Benefits of Animal Assisted Mindfulness
- Improved focus & concentration
- Increased self-awareness, self-acceptance, confidence
- Decreased anxiety & stress
- Enhanced physical, social, emotional self regulation
- Attuned communication skills
- Enriched ability to identify & shift challenging emotions
- Reduced fear
- Improved sleep
51
How does Animal Assisted Mindfulness Work
- Teach mindfulness strategies
- Give opportunities for practice with animals & at home with family
- Provide home support
52
Working with FASD Families
- No place for blames/shame
- Be present
- Suspend judgement
- Nurture own mental health
53
Forensic Mental Health
- People who commit criminal acts because of mental illness
- Criminal law deals fairly while protecting public from future crimes
54
Significant Threat
- Risk of physical/psychological harm
- Conduct giving rise to harm must be criminal nature
55
Not Guilty by Reason of Insanity
- Pre-1992
- Before NCR
- No consideration of dangerousness
56
Not Criminally Responsible (NCR)
No person is criminally responsible for an act committed or an omission made while suffering from a mental disorder that rendered the person incapable of appreciating the nature and quality of the act or omission or of knowing that it was wrong
*1992
57
Winko
- Granted conditional discharged
- Appealed
- Requested absolute discharge
- Claiming criminal code violated his charter rights
58
Impact of Winko
Hospital needs to clearly establish actions/behaviors of posing an actual risk of significant harm
59
Not Criminally Responsible Reform Act
- Real risk of physical/psychological harm to public that is serious
- Conduct giving rise to harm must be criminal in nature
- Post Winko
60
Forensic Challenges for IP Team
- Overcoming pattern of custodial care model
- Patients may not believe nurses hold their best interests
- Pt may view treatment with suspicion
- No individual confidentiality among treatment team & court
- Vicarious trauma
61
Relational Ethics
- Mutual respect
- Engagement
- Attention to environment